GeoPolitics Pulse

The Heartbeat of World events

European Commission Grants Second Indication Approval for TEPKINLY® (epcoritamab) for …

by ·

TEPKINLY (epcoritamab) is the first and only subcutaneous bispecific antibody conditionally approved as a monotherapy in the European Union to …Read More

Related posts:

  1. TEPKINLY® (epcoritamab) Receives Second European Commission Approval for … – Yahoo Finance
  2. TEPKINLY® (epcoritamab) Receives Second European Commission Approval for … – Morningstar
  3. TEPKINLY® (epcoritamab) Receives Second European Commission Approval for … – Business Wire
  4. Follicular Lymphoma Indication for Epcoritamab Bispecific Antibody Approved in Japan
  5. European Commission approves expanded age indication for GSK’s Arexvy, the first …